When you’re diagnosed with non-Hodgkin’s lymphoma (NHL), the next step is to find out the stage of your cancer. That tells you how much lymphoma is in your body, where it is, and if it has spread ...

Monjuvi shows real-world effectiveness in relapsed/refractory DLBCL, with 11.3 months PFS and 24.8 months OS. Second-line Monjuvi treatment yields higher ORR (78.5%) compared to third-line (62.8%).